United States · Funded startup

Who invested in Castle Creek Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$48Mraised across 1 round since 2016, from 1 source

Latest round
Round, $48MOct 2016
Investors
1
See who backed them

The rounds

  1. Oct 2016
    Round$48M

    Reported by FinSMEsSEC filing: $48M sold, first sale Sept 2016

Founders and team

From the SEC filings it signed: 2 on the team.

  • Michael DerbyChief Executive Officer and Secretaryi
  • Greg LicholaiPresidenti

On the board, as filediAntonio GraciasJeffrey AroninPatrick MorrisTimothy Cunniff

Everyone who backed them

FidelityVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Castle Creek Pharmaceuticals

Who invested in Castle Creek Pharmaceuticals?

Castle Creek Pharmaceuticals's investors include Fidelity.

How much has Castle Creek Pharmaceuticals raised?

Castle Creek Pharmaceuticals has raised $48M across 1 round since 2016.

When did Castle Creek Pharmaceuticals last raise?

Castle Creek Pharmaceuticals's most recent round was an Undisclosed round of $48M in Oct 2016.

What was Castle Creek Pharmaceuticals's biggest round?

Its most recent round, $48M in Oct 2016, is also its largest on record.

Who backed Castle Creek Pharmaceuticals first?

Castle Creek Pharmaceuticals's first round on record, in Oct 2016, was backed by Fidelity.

What stage is Castle Creek Pharmaceuticals at?

Castle Creek Pharmaceuticals's latest named round is an Undisclosed round, in Oct 2016.

Where is Castle Creek Pharmaceuticals based?

Castle Creek Pharmaceuticals is based in the United States.

Companies like Castle Creek Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.